Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M.

J Immunol. 2010 May 1;184(9):4801-9. doi: 10.4049/jimmunol.0902385. Epub 2010 Apr 5.

2.

Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.

Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF.

J Immunol. 2010 May 1;184(9):4789-800. doi: 10.4049/jimmunol.0902391. Epub 2010 Apr 5.

3.
4.

Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.

Tang X, Zhang B, Jarrell JA, Price JV, Dai H, Utz PJ, Strober S.

J Autoimmun. 2014 May;50:87-98. doi: 10.1016/j.jaut.2014.01.002. Epub 2014 Feb 7.

5.

IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.

Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S.

Am J Pathol. 2011 Feb;178(2):735-43. doi: 10.1016/j.ajpath.2010.10.022.

6.

Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.

Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D.

J Immunol. 2003 Mar 15;170(6):3392-400.

7.

Identifying regulatory B cells (B10 cells) that produce IL-10 in mice.

Matsushita T, Tedder TF.

Methods Mol Biol. 2011;677:99-111. doi: 10.1007/978-1-60761-869-0_7.

PMID:
20941605
8.

Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.

Morshed SR, Mannoor K, Halder RC, Kawamura H, Bannai M, Sekikawa H, Watanabe H, Abo T.

Eur J Immunol. 2002 Sep;32(9):2551-61.

9.

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.

Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M.

J Allergy Clin Immunol. 2013 Jun;131(6):1674-82. doi: 10.1016/j.jaci.2013.01.044. Epub 2013 Mar 25.

PMID:
23534976
10.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF.

Immunity. 2008 May;28(5):639-50. doi: 10.1016/j.immuni.2008.03.017.

11.

Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Matsushita T, Horikawa M, Iwata Y, Tedder TF.

J Immunol. 2010 Aug 15;185(4):2240-52. doi: 10.4049/jimmunol.1001307. Epub 2010 Jul 12.

12.

An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.

Wellmann U, Letz M, Schneider A, Amann K, Winkler TH.

Int Immunol. 2001 Dec;13(12):1461-9.

PMID:
11717187
14.

Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.

Horikawa M, Weimer ET, DiLillo DJ, Venturi GM, Spolski R, Leonard WJ, Heise MT, Tedder TF.

J Immunol. 2013 Feb 1;190(3):1158-68. doi: 10.4049/jimmunol.1201427. Epub 2012 Dec 28.

15.

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.

Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M.

Blood. 2013 Apr 18;121(16):3274-83. doi: 10.1182/blood-2012-11-465658. Epub 2013 Feb 19.

16.

Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.

Pau E, Chang NH, Loh C, Lajoie G, Wither JE.

Clin Immunol. 2011 May;139(2):215-27. doi: 10.1016/j.clim.2011.02.005. Epub 2011 Mar 17.

PMID:
21414847
17.

TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.

Hong J, Fang J, Lan R, Tan Q, Tian Y, Zhang M, Okunieff P, Zhang L, Lin J, Han D.

Mol Immunol. 2017 Mar;83:52-61. doi: 10.1016/j.molimm.2017.01.011. Epub 2017 Jan 18.

PMID:
28110075
18.

Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Postól E, Meyer A, Cardillo F, de Alencar R, Pessina D, Nihei J, Mariano M, Mengel J.

Immunology. 2008 Oct;125(2):184-96. doi: 10.1111/j.1365-2567.2008.02835.x. Epub 2008 Apr 7.

19.

Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.

Yang JQ, Wen X, Liu H, Folayan G, Dong X, Zhou M, Van Kaer L, Singh RR.

Arthritis Rheum. 2007 Apr;56(4):1219-33.

20.

CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.

Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF.

J Immunol. 1996 Nov 15;157(10):4371-8.

PMID:
8906812

Supplemental Content

Support Center